RSV-iiiQ Score | Mean (SD) | Test-retest ICC | Alpha Day 1, Day 2 | Construct Validity Correlations (Day 1) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sheehan Disability Scale | EQ-5D-5L | PGIS | ||||||||||||
Work/ School | Family Life/ Home | Days Lost | Days Unpro- ductive | Mobility | Usual Activities | Self-care | Pain/ Discomfort | Anxiety/ Depres-sion | VAS | |||||
Respiratory Symptoms | 1.15 (0.7) | 0.86 | 0.90, 0.90 | 0.65* | 0.61* | 0.34* | 0.45* | 0.41* | 0.43* | 0.37* | 0.61* | 0.26 | −0.54* | 0.78* |
Systemic Symptoms | 1.06 (0.7) | 0.80 | 0.88, 0.87 | 0.61* | 0.56* | 0.36* | 0.49* | 0.43* | 0.54* | 0.51* | 0.74* | 0.32* | −0.56* | 0.64* |
Functional Impacts | 0.99 (0.8) | 0.80 | 0.94, 0.94 | 0.69* | 0.67* | 0.42* | 0.48* | 0.49* | 0.61* | 0.56* | 0.61* | 0.29 | −0.57* | 0.76* |
Emotional Impacts | 1.15 (0.9) | 0.65 | 0.88, 0.91 | 0.66* | 0.62* | 0.36* | 0.39* | 0.38* | 0.44* | 0.40* | 0.46* | 0.45* | −0.51* | 0.60* |